Results 111 to 120 of about 28,682 (177)

Possible correlation of b3-a2-type bcr-abl messenger RNA defined by semiquantitative RT-PCR to platelet and megakaryocyte counts in Philadelphia-positive chronic myelogenous leukemia.

Internal medicine, 1994
K. Inokuchi, M. Futaki, K. Dan, T. Nomura   +3 more
semanticscholar   +1 more source

Computational Insights into the Polypharmacological Landscape of BCR-ABL Inhibitors: Emphasis on Imatinib and Nilotinib. [PDF]

Pharmaceuticals (Basel)
Hajjo R, Sabbah DA, Alhaded R, Alquabe'h A, Bardaweel SK.   +4 more
europepmc   +1 more source

Lactate-mediated activation of GPR81 regulates BCR/Abl protein expression in chronic myeloid leukemia cells selected under low oxygen tension. [PDF]

J Pathol
Menegazzi G, Desideri D, Biagioni A, Rovida E, Dello Sbarba P, Peppicelli S.   +5 more
europepmc   +1 more source

Uncommon phenotypes of <i>BCR::ABL1</i>-positive chronic myelogenous leukemia. [PDF]

Haematologica
Jajosky AN, Lichtman MA.
europepmc   +1 more source

Dasatinib-Associated Recurrent Symptomatic Bilateral Pleural Effusions in an Elderly Patient With End-Stage Renal Disease on Maintenance Hemodialysis. [PDF]

Cureus
Onuigbo MA, Butler M, Biediger J.
europepmc   +1 more source

An Automated Cartridge-Based Microfluidic System for Real-Time Quantification of <i>BCR::ABL1</i> Transcripts in Chronic Myeloid Leukemia: An Italian Experience. [PDF]

Int J Mol Sci
Danzero AC, Gottardi EM, Quarantelli F, Del Prete C, Potenza A, Venturi C, Berchialla P, Guerrini F, Bono C, Ottaviani E, Galimberti S, Fava C, Izzo B.   +12 more
europepmc   +1 more source

Potential signaling pathways, biomarkers, natural drugs, and chronic myeloid leukemia therapeutics. [PDF]

Front Pharmacol
Alqahtani S.
europepmc   +1 more source

Ponatinib for CML patients in routine clinical practice: the PONDEROSA study. [PDF]

Ann Hematol
Schenk T, Fabisch C, Ernst T, Ernst P, Saussele S, Žáčková D, Mayer J, Klamová H, Hochhaus A, German CML Study Group and the Czech Leukemia Study Group.   +9 more
europepmc   +1 more source

Concurrent NPM1::CCDC28A and BCR::ABL1 fusions in extramedullary blast crisis of chronic myeloid leukemia: A case report and literature review. [PDF]

Ann Hematol
Zhu L, Yi K, Zhou J, Hu G, He J, Lan H, Chen M, Sun L, Zheng B, Li R.   +9 more
europepmc   +1 more source

Natural Products Targeting BCR-ABL: A Plant-Based Approach to Chronic Myeloid Leukemia Treatment. [PDF]

Molecules
Pechlivani L, Giannakis A, Sioka C, Alexiou GA, Kyritsis AP.   +4 more
europepmc   +1 more source